Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity

616 610
DOI: 10.1016/j.ymthe.2025.02.024 Publication Date: 2025-02-15T23:57:26Z